Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole

Published:2022-02-23 Issue:7 Volume:88 Page:3288-3296
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Yang Eunsol¹^ORCID,Kim Seokuee²,Kim Bongtae²,Kim Boram³,Kim Yechan³,Park Sung Sup³,Song Geun Seog²,Yu Kyung‐Sang¹^ORCID,Jang In‐Jin¹,Lee SeungHwan¹

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics Seoul National University College of Medicine and Hospital Seoul Republic of Korea

2. Division of Clinical Development HK inno. N Corp. Seoul Republic of Korea

3. Department of Laboratory Medicine Seoul National University College of Medicine and Hospital Seoul Republic of Korea

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15268

Reference38 articles.

1. Gastroesophageal Reflux Disease

2. Gastroesophageal Reflux Disease

3. Appropriate Acid Suppression for the Management of Gastro-Oesophageal Reflux Disease

4. Nocturnal acid breakthrough ‐ approach to management;Tutuian R;MedGenMed,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27

2. Efficacy and safety of tegoprazan‐ and rabeprazole‐based concomitant therapies for Helicobacter pylori infection: Real‐world evidence;Journal of Gastroenterology and Hepatology;2024-08-26

3. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15

4. Evaluating vonoprazan and tegoprazan for gastroesophageal reflux disease treatment in Chinese Healthcare: an EVIDEM framework analysis;BMC Gastroenterology;2024-06-20

5. In Vitro Metabolism and Transport Characteristics of Zastaprazan;Pharmaceutics;2024-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3